112 related articles for article (PubMed ID: 35328730)
1. miRNAs in Cardiac Myxoma: New Pathologic Findings for Potential Therapeutic Opportunities.
Nenna A; Loreni F; Giacinto O; Chello C; Nappi P; Chello M; Nappi F
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328730
[TBL] [Abstract][Full Text] [Related]
2. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
3. Diabetes induces dysregulation of microRNAs associated with survival, proliferation and self-renewal in cardiac progenitor cells.
Purvis N; Kumari S; Chandrasekera D; Bellae Papannarao J; Gandhi S; van Hout I; Coffey S; Bunton R; Sugunesegran R; Parry D; Davis P; Williams MJA; Bahn A; Katare R
Diabetologia; 2021 Jun; 64(6):1422-1435. PubMed ID: 33655378
[TBL] [Abstract][Full Text] [Related]
4. miR-217 suppresses proliferation and promotes apoptosis in cardiac myxoma by targeting Interleukin-6.
Zhang J; Wang C; Xu H
Biochem Biophys Res Commun; 2017 Aug; 490(3):713-718. PubMed ID: 28642131
[TBL] [Abstract][Full Text] [Related]
5. miR-218 suppresses cardiac myxoma proliferation by targeting myocyte enhancer factor 2D.
Cao Q; Dong P; Wang Y; Zhang J; Shi X; Wang Y
Oncol Rep; 2015 May; 33(5):2606-12. PubMed ID: 25812649
[TBL] [Abstract][Full Text] [Related]
6. Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis.
Braza-Boïls A; Salloum-Asfar S; Marí-Alexandre J; Arroyo AB; González-Conejero R; Barceló-Molina M; García-Oms J; Vicente V; Estellés A; Gilabert-Estellés J; Martínez C
Hum Reprod; 2015 Oct; 30(10):2292-302. PubMed ID: 26307093
[TBL] [Abstract][Full Text] [Related]
7. The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.
Li H; Xie S; Liu M; Chen Z; Liu X; Wang L; Li D; Zhou Y
Int J Oncol; 2014 Jul; 45(1):197-208. PubMed ID: 24805774
[TBL] [Abstract][Full Text] [Related]
8. High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth.
Leivonen SK; Sahlberg KK; Mäkelä R; Due EU; Kallioniemi O; Børresen-Dale AL; Perälä M
Mol Oncol; 2014 Feb; 8(1):93-104. PubMed ID: 24148764
[TBL] [Abstract][Full Text] [Related]
9. Loss of has-miR-337-3p expression is associated with lymph node metastasis of human gastric cancer.
Wang Z; Wang J; Yang Y; Hao B; Wang R; Li Y; Wu Q
J Exp Clin Cancer Res; 2013 Oct; 32(1):76. PubMed ID: 24422944
[TBL] [Abstract][Full Text] [Related]
10. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-focused CRISPR-Cas9 library screen reveals fitness-associated miRNAs.
Kurata JS; Lin RJ
RNA; 2018 Jul; 24(7):966-981. PubMed ID: 29720387
[TBL] [Abstract][Full Text] [Related]
12. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
13. MiR-193a-5p and -3p Play a Distinct Role in Gastric Cancer: miR-193a-3p Suppresses Gastric Cancer Cell Growth by Targeting ETS1 and CCND1.
Chou NH; Lo YH; Wang KC; Kang CH; Tsai CY; Tsai KW
Anticancer Res; 2018 Jun; 38(6):3309-3318. PubMed ID: 29848678
[TBL] [Abstract][Full Text] [Related]
14. Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma.
Chen Z; Saad R; Jia P; Peng D; Zhu S; Washington MK; Zhao Z; Xu Z; El-Rifai W
Cancer; 2013 Jun; 119(11):1985-93. PubMed ID: 23456798
[TBL] [Abstract][Full Text] [Related]
15. miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase.
Chen L; Lü MH; Zhang D; Hao NB; Fan YH; Wu YY; Wang SM; Xie R; Fang DC; Zhang H; Hu CJ; Yang SM
Cell Death Dis; 2014 Jan; 5(1):e1034. PubMed ID: 24481448
[TBL] [Abstract][Full Text] [Related]
16. Three novel microRNAs based on microRNA signatures for gastric mucosa-associated lymphoid tissue lymphoma.
Zhang Y; Liu A; E M; Quan L; Qu Y; Gu A
Neoplasma; 2018 Mar; 65(3):339-348. PubMed ID: 29788729
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of microRNAs in gastric cancer and biological significance of miR-574-3p.
Su Y; Ni Z; Wang G; Cui J; Wei C; Wang J; Yang Q; Xu Y; Li F
Int Immunopharmacol; 2012 Aug; 13(4):468-75. PubMed ID: 22683180
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study.
Moi L; Braaten T; Al-Shibli K; Lund E; Busund LR
J Transl Med; 2019 Oct; 17(1):334. PubMed ID: 31581940
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]